肥厚型心肌病合并心房颤动的导管消融

Catheter Ablation of Hypertrophic Cardiomyopathy with Atrial Fibrillation

心房颤动是肥厚型心肌病患者较为常见的心律失常。相较于普通心房颤动患者,肥厚型心肌病患者有着更高的卒中、心力衰竭及猝死等风险。抗心律失常药在控制心室率及维持窦性心律中应用广泛,但较低的有效率和较多的药物副作用使得药物应用受限。导管消融治疗心房颤动具有安全性高、并发症少以及有效性可靠等特点,对于合并肥厚型心肌病的心房颤动患者,导管消融可能成为临床上重要的治疗手段。

Atrial fibrillation is a common arrhythmia in patients with hypertrophic cardiomyopathy.Compared with ordinary patients with atrial fibrillation,patients with hypertrophic cardiomyopathy have a higher risk of stroke,heart failure and sudden death.Antiarrhymic drugs are widely used in controlling ventricular rate and maintaining sinus rhythm,but the lower effective rate and more side effects of drugs make the application of drugs limited.Catheter ablation in the treatment of atrial fibrillation has the characteristics of high safety,fewer complications and reliable effectiveness.For patients with atrial fibrillation combined with hypertrophic cardiomyopathy,catheter ablation may become a first-line treatment.